Be SMART
bioMérieux, an in vitro diagnostics company, heightened its role in the fight against antimicrobial resistance by launching its Solutions to Manage the Antimicrobial Resistance Threat (SMART) Campaign at the 49th Annual Interscience Conference for Antimicrobial Agents and Chemotherapy (ICAAC) event in San Francisco.
bioMerieux's SMART Campaign (biomerieux-usa.com/smart) seeks to create more educational resources for the lab and to provide healthcare professionals with relevant tools and resources to identify, monitor, prevent and track resistance. Key areas of focus include:
-
Identifying Resistance: help clinicians get clear actionable information, so they can begin effective antibiotic therapy as early as possible.
-
Monitoring Resistance: surveillance of antimicrobial resistance patterns at all levels--national, local, hospital and ward level is essential to set up effective antimicrobial policies.
-
Tracking Resistance: screening of patients and healthcare workers for multi-drug resistant organisms is a key measure to contain the spread of resistance
-
Preventing Resistance: differentiation between viral and bacterial infections.
-
Educating Resistance: promote scientific forums, documents and agreements to promote further information exchange and education on this key public health issue.
"This is a race against time, and the options are quite limited in the antimicrobial drug pipeline. bioMérieux's SMART Campaign's goal is to help healthcare professional with their daily battle to contain and reduce antimicrobial resistance, said Herb Steward, executive vice president and general manager, bioMérieux North America.
As part of its commitment to fight HAIs, bioMérieux has organized HAI symposia around the world including events in the U.S., Belgium, the Netherlands, Portugal, Spain, Japan and Korea throughout the past 2 years.